Quick Answer
Wellgistics Health, Inc. reported Diluted EPS of $1.43 per share (loss) for fiscal year 2025.
Wellgistics Health, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.43 | -853.3% |
| 2024 | -$0.15 | -150.0% |
| 2023 | -$0.06 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.46 | -1050.0% | -318.2% |
| June 30, 2025 | -$0.11 | -1000.0% | +82.3% |
| March 31, 2025 | -$0.62 | — | -1450.0% |
| September 30, 2024 | -$0.04 | — | -300.0% |
| June 30, 2024 | -$0.01 | — | — |
| March 31, 2024 | $0.00 | — | — |
- Wellgistics Health, Inc. showed a decrease of -853.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2025 period, Wellgistics Health, Inc.’s diluted eps has declined by 2283.3% (from $0.06 per share (loss) to $1.43 per share (loss)).
- The most recent figure is from Wellgistics Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: